GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · IEX Real-Time Price · USD
3.480
+0.310 (9.78%)
May 2, 2024, 10:42 AM EDT - Market open
GTBP's stock price has decreased by -71.44% in the past year and price targets may not have had time to catch up.
GT Biopharma Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
$105.00
Upside
+2,917.24%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +4,210.34% | Aug 8, 2023 |
| EF Hutton | EF Hutton | Hold Reiterates $60 | Hold | Reiterates | $60 | +1,624.14% | Aug 7, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +4,210.34% | Jun 5, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +4,210.34% | May 17, 2023 |
| EF Hutton | EF Hutton | Hold Reiterates $60 | Hold | Reiterates | $60 | +1,624.14% | May 16, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +4,210.34% | Apr 3, 2023 |
| EF Hutton | EF Hutton | Hold Reiterates $60 | Hold | Reiterates | $60 | +1,624.14% | Mar 31, 2023 |
| EF Hutton | EF Hutton | Hold Initiates $60 | Hold | Initiates | $60 | +1,624.14% | Jan 5, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $750 → $150 | Strong Buy | Maintains | $750 → $150 | +4,210.34% | Sep 13, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $750 | Strong Buy | Initiates | $750 | +21,451.72% | May 24, 2021 |
| Roth Capital | Roth Capital | Strong Buy Initiates $750 | Strong Buy | Initiates | $750 | +21,451.72% | Mar 17, 2021 |